UPIC Audits of Toxicology and Drug Testing Labs

Unified Program Integrity Contractor (UPIC) audits of toxicology and drug testing labs turn on one question: whether definitive drug testing was medically necessary for each patient, on each date of service, or billed by default. A UPIC that finds a pattern of unnecessary testing can extrapolate the error rate across the full audit period, place the lab on prepayment review, and refer the matter for further investigation. Physicians who order the testing carry parallel exposure, because the medical record, not the lab's test menu, is where medical necessity has to be documented.

Why UPICs Are Watching Definitive Testing

A February 2023 HHS Office of Inspector General report found that Medicare paid $704.2 million over five years for definitive drug testing services at risk of noncompliance, and could have saved up to $216 million with adequate program safeguards. The report identified 1,062 providers who routinely billed HCPCS code G0483, the code for definitive testing of 22 or more drug classes, for most of their testing volume, a pattern the OIG treated as a signal of unnecessary testing rather than individualized clinical decisions.

Enforcement has followed the data. In October 2024, the Department of Justice announced a $27 million settlement with Precision Toxicology over allegations that the lab promoted standing test panels that caused physicians to order tests without an individualized assessment of each patient. In July 2026, the Department of Justice announced a $14.5 million settlement with Labcorp over allegations that it billed both a presumptive test and the highest-tier definitive test for the same patient, on the same date of service, from the same urine sample.

Definitive Testing Requires an Individualized Reason

Medicare pays for presumptive urine drug testing under CPT codes 80305 through 80307, billed once per day regardless of the method used, and for definitive testing under HCPCS codes G0480 through G0483 and G0659, also billed once per day. CMS coverage policy treats definitive testing as reasonable and necessary only when the ordering clinician can point to a specific reason it was needed for that patient: a presumptive result that conflicts with the patient's reported history, a substance a presumptive screen cannot detect, or a concentration needed to guide a specific treatment decision. The standard is not the drug class count on the lab's requisition. It is the clinician's documented reasoning for that patient, on that date.

A drug class count on a lab requisition is not a medical necessity finding. The medical record has to show why that patient needed that test, on that date.

Custom Panels Shift the Documentation Burden to the Ordering Physician

UPIC toxicology audits focus heavily on custom or standing panels, pre-built test combinations a lab markets to a physician practice for routine use. The HHS Office of Inspector General has cautioned that a panel makes it harder for the ordering physician to make an independent medical necessity determination for each individual test. A UPIC records request in a toxicology matter typically asks for more than the order and the signature log. It asks for the clinical note explaining why a definitive panel, rather than a screen, was medically necessary for that visit. A signature log documents that a physician signed the order. It does not document why the physician ordered 22 or more drug classes instead of a presumptive screen, and UPIC reviewers know the difference.

Extrapolation, Recoupment, and Referral to Law Enforcement

When a sample of claims fails a UPIC's medical necessity review, the contractor extrapolates the error rate across the full lookback period, turning a handful of flagged claims into a six- or seven-figure recoupment demand. Labs and ordering practices are also routinely placed on prepayment review while the audit continues, halting cash flow on new claims rather than only clawing back old ones. UPIC prepayment review has its own exit process, separate from the underlying medical necessity dispute. A pattern the UPIC characterizes as intentional, rather than a documentation gap, can be referred to law enforcement. That referral can arrive as a target letter naming the lab, the ordering physicians, or both, and what happens after that referral is a different and higher-stakes proceeding than the audit that started it.

Why Early Legal Counsel Is Critical

It is critical that toxicology labs and the physicians who order their testing promptly retain experienced healthcare defense counsel upon receiving a UPIC records request, an audit notice, or any related government inquiry. Early legal intervention can protect the provider's rights, ensure appropriate responses to government requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the provider's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the provider to unnecessary risk.

How Health Law Alliance Can Help

Health Law Alliance defends toxicology labs and the physicians who order their testing against UPIC audits nationwide, with 2,000+ audits overseen across the bench. If your lab or practice is facing a UPIC toxicology audit, contact our UPIC audit defense team for a free, confidential consultation before you respond.